Arterial Stiffness and Diabetes Risk in Framingham Heart Study and UK Biobank
- PMID: 35946401
- PMCID: PMC7613487
- DOI: 10.1161/CIRCRESAHA.122.320796
Arterial Stiffness and Diabetes Risk in Framingham Heart Study and UK Biobank
Abstract
Background: Microvascular damage from large artery stiffness (LAS) in pancreatic, hepatic, and skeletal muscles may affect glucose homeostasis. Our goal was to evaluate the association between LAS and the risk of type 2 diabetes using prospectively collected, carefully phenotyped measurements of LAS as well as Mendelian randomization analyses.
Methods: Carotid-femoral pulse wave velocity (CF-PWV) and brachial and central pulse pressure were measured in 5676 participants of the FHS (Framingham Heart Study) without diabetes. We used Cox proportional hazards regression to evaluate the association of CF-PWV and pulse pressure with incident diabetes. We subsequently performed 2-sample Mendelian randomization analyses evaluating the associations of genetically predicted brachial pulse pressure with type 2 diabetes in the UKBB (United Kingdom Biobank).
Results: In FHS, individuals with higher CF-PWV were older, more often male, and had higher body mass index and mean arterial pressure compared to those with lower CF-PWV. After a median follow-up of 7 years, CF-PWV and central pulse pressure were associated with an increased risk of new-onset diabetes (per SD increase, multivariable-adjusted CF-PWV hazard ratio, 1.36 [95% CI, 1.03-1.76]; P=0.030; central pulse pressure multivariable-adjusted CF-PWV hazard ratio, 1.26 [95% CI, 1.08-1.48]; P=0.004). In United Kingdom Biobank, genetically predicted brachial pulse pressure was associated with type 2 diabetes, independent of mean arterial pressure (adjusted odds ratio, 1.16 [95% CI, 1.00-1.35]; P=0.049).
Conclusions: Using prospective cohort data coupled with Mendelian randomization analyses, we found evidence supporting that greater LAS is associated with increased risk of developing diabetes. LAS may play an important role in glucose homeostasis and may serve as a useful marker of future diabetes risk.
Keywords: blood pressure; carotid-femoral pulse wave velocity; hemodynamics; human genetics; vascular stiffness.
Conflict of interest statement
DISCLOSURES
JAC has recently consulted for Bayer, Sanifit, Fukuda-Denshi, Bristol-Myers Squibb, JNJ, Edwards Life Sciences, Merck, NGM Biopharmaceuticals and the Galway-Mayo Institute of Technology. He received University of Pennsylvania research grants from National Institutes of Health, Fukuda-Denshi, Bristol-Myers Squibb, Microsoft and Abbott. He is named as inventor in a University of Pennsylvania patent for the use of inorganic nitrates/nitrites for the treatment of Heart Failure and Preserved Ejection Fraction and for the use of biomarkers in heart failure with preserved ejection fraction. He has received payments for editorial roles from the American Heart Association, the American College of Cardiology and Wiley. He has received research device loans from Atcor Medical, Fukuda-Denshi, Unex, Uscom, NDD Medical Technologies, Microsoft and MicroVision Medical. GFM is the owner of Cardiovascular Engineering, Inc., a small business that designs and develops devices that are used to measure arterial stiffness and has received consulting fees or grants from Novartis, Merck, Bayer and Servier. DG is employed part-time by Novo Nordisk. The remaining authors have nothing to disclose.
Figures
Comment in
-
Metabolic Endotoxemia and Arterial Stiffness in Diabetes.Circ Res. 2022 Sep 2;131(6):555-557. doi: 10.1161/CIRCRESAHA.122.321702. Epub 2022 Sep 1. Circ Res. 2022. PMID: 36048920 No abstract available.
References
-
- Townsend RR, Wilkinson IB, Schiffrin EL, Avolio AP, Chirinos JA, Cockcroft JR, Heffernan KS, Lakatta EG, McEniery CM, Mitchell GF, et al. Recommendations for Improving and Standardizing Vascular Research on Arterial Stiffness: A Scientific Statement From the American Heart Association. Hypertension. 2015;66:698–722. doi: 10.1161/HYP.0000000000000033 - DOI - PMC - PubMed
-
- Townsend RR, Anderson AH, Chirinos JA, Feldman HI, Grunwald JE, Nessel L, Roy J, Weir MR, Wright JT, Bansal N Jr., et al. Association of Pulse Wave Velocity With Chronic Kidney Disease Progression and Mortality: Findings From the CRIC Study (Chronic Renal Insufficiency Cohort). Hypertension. 2018;71:1101–1107. doi: 10.1161/HYPERTENSIONAHA.117.10648 - DOI - PMC - PubMed
-
- Nichols WW ORM, Vlachopoulos C. McDonald’s Blood Flow in Arteries: Theoretical, Experimental and Clinical Principles, 6th Edition. Hodder Arnold. 2011.
Publication types
MeSH terms
Substances
Grants and funding
- R01 HL071039/HL/NHLBI NIH HHS/United States
- K23 HL133843/HL/NHLBI NIH HHS/United States
- R01 HL155599/HL/NHLBI NIH HHS/United States
- HHSN268201500001C/HL/NHLBI NIH HHS/United States
- K24 AG070459/AG/NIA NIH HHS/United States
- R01 HL076784/HL/NHLBI NIH HHS/United States
- R01 HL060040/HL/NHLBI NIH HHS/United States
- R01 HL104106/HL/NHLBI NIH HHS/United States
- MC_UU_00002/7/MRC_/Medical Research Council/United Kingdom
- R01 HL077447/HL/NHLBI NIH HHS/United States
- R56 HL136730/HL/NHLBI NIH HHS/United States
- R01 HL153646/HL/NHLBI NIH HHS/United States
- U01 HL160277/HL/NHLBI NIH HHS/United States
- U01 DK060990/DK/NIDDK NIH HHS/United States
- 204623/Z/16/Z/WT_/Wellcome Trust/United Kingdom
- R01 HL070100/HL/NHLBI NIH HHS/United States
- R01 AG074989/AG/NIA NIH HHS/United States
- MC_QA137853/MRC_/Medical Research Council/United Kingdom
- U01 TR003734/TR/NCATS NIH HHS/United States
- U24 DK060990/DK/NIDDK NIH HHS/United States
- R03 HL146874/HL/NHLBI NIH HHS/United States
- P01 HL094307/HL/NHLBI NIH HHS/United States
- R01 HL157108/HL/NHLBI NIH HHS/United States
- R01 HL157264/HL/NHLBI NIH HHS/United States
- N01 HC025195/HL/NHLBI NIH HHS/United States
- R01 HL121510/HL/NHLBI NIH HHS/United States
- HHSN268201500001I/HL/NHLBI NIH HHS/United States
- R01 AG058969/AG/NIA NIH HHS/United States
- 75N92019D00031/HL/NHLBI NIH HHS/United States
- R01 DK123104/DK/NIDDK NIH HHS/United States
- MC_PC_17228/MRC_/Medical Research Council/United Kingdom
- R01 HL080124/HL/NHLBI NIH HHS/United States
- R01 HL142983/HL/NHLBI NIH HHS/United States
- R33 HL146390/HL/NHLBI NIH HHS/United States
- R01 AG028321/AG/NIA NIH HHS/United States
- R01 HL126136/HL/NHLBI NIH HHS/United States
- MR/S019669/1/MRC_/Medical Research Council/United Kingdom
LinkOut - more resources
Full Text Sources
Medical
